Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.28 USD | +2.50% | -6.55% | +92.94% |
Apr. 25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 24.5M |
---|---|---|---|---|---|
Net income 2022 | -9M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 42.06M | Net cash position 2023 | 37.15M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.44
x | P/E ratio 2023 |
-4.59
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.71% |
1 day | +2.50% | ||
1 week | -6.55% | ||
Current month | -11.35% | ||
1 month | -5.48% | ||
3 months | +99.39% | ||
6 months | +81.22% | ||
Current year | +92.94% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 06-09-30 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 21-05-09 |
Sharon Perry
LAW | General Counsel | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 17-02-15 |
Robert Conway
CHM | Chairman | 70 | 13-09-02 |
Linda Grais
BRD | Director/Board Member | 68 | 07-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 3.28 | +2.50% | 13,612 |
24-06-10 | 3.2 | -2.44% | 124,738 |
24-06-07 | 3.28 | -0.91% | 30,615 |
24-06-06 | 3.31 | 0.00% | 70,287 |
24-06-05 | 3.31 | -5.70% | 54,184 |
Delayed Quote Nasdaq, June 11, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+92.94% | 47.58M | |
+18.34% | 124B | |
+15.06% | 109B | |
-6.39% | 23.84B | |
+1.02% | 22.42B | |
-14.64% | 17.5B | |
-41.64% | 16.43B | |
-12.07% | 16.61B | |
+1.05% | 13.4B | |
+25.87% | 11.47B |
- Stock Market
- Equities
- ABIO Stock